Table 1 Summary of patient cohorts with clinico-patohologic characteristics
From: A prognostic model based on cell-cycle control predicts outcome of breast cancer patients
Cohort I | Cohort II | ||
|---|---|---|---|
All subtypes (n = 781) | Luminal (n = 208) | TNBC (n = 146) | |
Mean age at diagnosis (range) (years) | 61 (28–95) | 62 (42–76) | 60 (39–78) |
Axillary lymph node positive (%) | 44.8 | 22.8 | 32.1 |
Mean tumor size (range) (cm) | 2.3 (0.2–16.0) | 1.9 (0.4–7.0) | 2.5 (0.2–18.0) |
Histological type (%) | |||
Infiltrating ductal NOS | 75. 4 | 72.3 | 100 |
Special type | 24.6 | 27.2 | 0 |
Intrinsic subtype (%) | |||
Luminal | 67.6 | 100 | – |
Her2-amplified | 18.6 | – | – |
Triple-negative | 13.8 | – | 100 |
Histological grade (%) | |||
Low (1-2) | 79.6 | 81.6 | 0 |
High (3) | 20.4 | 18.4 | 100 |
Median follow-up time (max) (years) | 12.4 (22.7) | 11.8 (14.0) | 6.9 (17.8) |
Dead of breast cancer (%) | 30.7 | 10.7 | 22.6 |